ℹ️
🇬🇧
Search
Search for people relevant for "lymphoma"
lymphoma
Person
Class
Person
Publication
Programmes
Export current view
MUDr. Martin Šimkovič Ph.D.
Academic staff at Faculty of Medicine in Hradec Králové
90 publications
Publications
publication
Maintenance rituximab in newly diagnosed mantle cell lymphoma patients: a real world analysis from the Czech lymphoma study group registry
2019 |
Faculty of Medicine in Hradec Králové, Third Faculty of Medicine, First Faculty of Medicine, Second Faculty of Medicine
publication
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial
2019 |
Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
publication
Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders
2019 |
Faculty of Medicine in Hradec Králové
publication
Is percutaneous computed tomography-guided biopsy sufficient to establish indolent lymphoma transformation?
2019 |
Faculty of Medicine in Hradec Králové
publication
Alternating R-CHOP and R-cytarabine is a safe and effective regimen for transplant-ineligible patients with a newly diagnosed mantle cell lymphoma
2018 |
Faculty of Medicine in Hradec Králové, Third Faculty of Medicine, First Faculty of Medicine, Second Faculty of Medicine
publication
Potential loss of prognostic significance of minimal residual disease assessment after R-CHOP-based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance
2018 |
Faculty of Medicine in Hradec Králové, Third Faculty of Medicine, First Faculty of Medicine, Second Faculty of Medicine
publication
Primary testicular lymphoma
2017 |
Faculty of Medicine in Hradec Králové
publication
Treatment of patients with recurrent/refractory aggressive non-Hodgkin's lymphoma: effectiveness and safety of pixantrone
2016 |
Faculty of Medicine in Hradec Králové
publication
Report of University Hospital Hradec Králové to the clinical trial protocol No: PCYC-1115-CA
Publication without faculty affiliation
publication
Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)
2023 |
Faculty of Medicine in Hradec Králové, Third Faculty of Medicine, First Faculty of Medicine
Load more publications (80)
Loading network view...